Nath Bio-Genes Q2 FY26: revenue 16% up, PAT Rs 42.4 cr

Negative operating cash flowExceptional itemResults View source PDF Explain this filing

NATHBIOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹166.78

prior close

₹168.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+0.8% vs market

Other Agricultural Products peers, median of 54sector+0.0%+0.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.7 pts more than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.1

15m

-0.2

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7-0.1+0.8+0.0+0.7

Next day

+0.7+0.5+0.2-1.4+2.1

-1.7-0.3-1.4-2.0+0.3

-2.9-0.5-2.4-1.7-1.2

-3.2-0.8-2.4-2.7-0.4

-4.7-2.3-2.4-2.8-1.9

-8.9-2.8-6.1-4.9-4.0

15d

-14.1-4.9-9.2-4.2-9.9

-8.5-4.7-3.8-6.3-2.2

-11.0-7.7-3.2-9.3-1.7

-11.8-7.8-3.9-9.3-2.4

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone H1 FY26 revenue at Rs 319.94 cr, up 15.9 percent YoY. PAT at Rs 42.41 cr, up 15.3 percent YoY. However, operating cash flow turned sharply negative at minus Rs 110.67 cr versus positive Rs 26.79 cr for FY25. Cash balance fell to Rs 0.35 cr from Rs 87.63 cr. Exceptional income of Rs 2.06 cr recorded. Short term borrowings rose to Rs 140.63 cr from Rs 109.52 cr.

Likely market impact

Profit growth is positive but operating cash burn is a concern; cash position sharply weaker.